ID   SCD5_HUMAN              Reviewed;         330 AA.
AC   Q86SK9; B2RPG0; Q4W5Q5; Q8NDS0; Q9H7D1;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   15-MAR-2017, entry version 113.
DE   RecName: Full=Stearoyl-CoA desaturase 5 {ECO:0000305};
DE            EC=1.14.19.1 {ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797};
DE   AltName: Full=Acyl-CoA-desaturase 4;
DE   AltName: Full=HSCD5 {ECO:0000303|PubMed:15907797};
DE   AltName: Full=Stearoyl-CoA 9-desaturase {ECO:0000303|PubMed:15907797};
DE   AltName: Full=Stearoyl-CoA desaturase 2 {ECO:0000303|PubMed:15610069};
GN   Name=SCD5; Synonyms=ACOD4, SCD2 {ECO:0000303|PubMed:15610069}, SCD4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=12727354; DOI=10.1016/S0378-1119(03)00461-X;
RA   Beiraghi S., Zhou M., Talmadge C.B., Went-Sumegi N., Davis J.R.,
RA   Huang D., Saal H., Seemayer T.A., Sumegi J.;
RT   "Identification and characterization of a novel gene disrupted by a
RT   pericentric inversion inv(4)(p13.1q21.1) in a family with cleft lip.";
RL   Gene 309:11-21(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Endothelial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 171-330.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15907797; DOI=10.1016/j.bbrc.2005.05.013;
RA   Wang J., Yu L., Schmidt R.E., Su C., Huang X., Gould K., Cao G.;
RT   "Characterization of HSCD5, a novel human stearoyl-CoA desaturase
RT   unique to primates.";
RL   Biochem. Biophys. Res. Commun. 332:735-742(2005).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND SUBUNIT.
RX   PubMed=15610069; DOI=10.1042/BJ20041554;
RA   Zhang S., Yang Y., Shi Y.;
RT   "Characterization of human SCD2, an oligomeric desaturase with
RT   improved stability and enzyme activity by cross-linking in intact
RT   cells.";
RL   Biochem. J. 388:135-142(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Stearyl-CoA desaturase that utilizes O(2) and electrons
CC       from reduced cytochrome b5 to introduce the first double bond into
CC       saturated fatty acyl-CoA substrates. Catalyzes the insertion of a
CC       cis double bond at the delta-9 position into fatty acyl-CoA
CC       substrates including palmitoyl-CoA and stearoyl-CoA
CC       (PubMed:15907797, PubMed:15610069). Gives rise to a mixture of
CC       16:1 and 18:1 unsaturated fatty acids.
CC       {ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797}.
CC   -!- CATALYTIC ACTIVITY: Stearoyl-CoA + 2 ferrocytochrome b5 + O(2) + 2
CC       H(+) = oleoyl-CoA + 2 ferricytochrome b5 + 2 H(2)O.
CC       {ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797}.
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000250|UniProtKB:P13516};
CC       Note=Expected to bind 2 Fe(2+) ions per subunit.
CC       {ECO:0000250|UniProtKB:P13516};
CC   -!- SUBUNIT: May self-associate and form homodimers.
CC       {ECO:0000269|PubMed:15610069}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15907797}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15907797}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86SK9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q86SK9-2; Sequence=VSP_029883;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in fetal brain, and at lower levels
CC       in fetal kidney. Detected in adult brain and pancreas, and at
CC       lower levels in kidney and lung. {ECO:0000269|PubMed:12727354,
CC       ECO:0000269|PubMed:15610069, ECO:0000269|PubMed:15907797}.
CC   -!- DOMAIN: The histidine box domains are involved in binding the
CC       catalytic metal ions. {ECO:0000250|UniProtKB:O00767}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF389338; AAP31443.1; -; mRNA.
DR   EMBL; AK024685; BAB14961.1; -; mRNA.
DR   EMBL; AC073413; AAY40977.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05903.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05904.1; -; Genomic_DNA.
DR   EMBL; BC137429; AAI37430.1; -; mRNA.
DR   EMBL; BC137432; AAI37433.1; -; mRNA.
DR   EMBL; AL831891; CAD38567.1; -; mRNA.
DR   CCDS; CCDS34024.1; -. [Q86SK9-1]
DR   CCDS; CCDS3595.1; -. [Q86SK9-2]
DR   RefSeq; NP_001032671.2; NM_001037582.2. [Q86SK9-1]
DR   RefSeq; NP_079182.2; NM_024906.2. [Q86SK9-2]
DR   UniGene; Hs.379191; -.
DR   ProteinModelPortal; Q86SK9; -.
DR   SMR; Q86SK9; -.
DR   BioGrid; 123034; 5.
DR   IntAct; Q86SK9; 2.
DR   STRING; 9606.ENSP00000316329; -.
DR   BindingDB; Q86SK9; -.
DR   ChEMBL; CHEMBL1275210; -.
DR   SwissLipids; SLP:000001074; -.
DR   iPTMnet; Q86SK9; -.
DR   PhosphoSitePlus; Q86SK9; -.
DR   BioMuta; SCD5; -.
DR   DMDM; 162416247; -.
DR   EPD; Q86SK9; -.
DR   MaxQB; Q86SK9; -.
DR   PaxDb; Q86SK9; -.
DR   PeptideAtlas; Q86SK9; -.
DR   PRIDE; Q86SK9; -.
DR   Ensembl; ENST00000273908; ENSP00000273908; ENSG00000145284. [Q86SK9-2]
DR   Ensembl; ENST00000319540; ENSP00000316329; ENSG00000145284. [Q86SK9-1]
DR   GeneID; 79966; -.
DR   KEGG; hsa:79966; -.
DR   UCSC; uc003hna.3; human. [Q86SK9-1]
DR   CTD; 79966; -.
DR   DisGeNET; 79966; -.
DR   GeneCards; SCD5; -.
DR   HGNC; HGNC:21088; SCD5.
DR   HPA; HPA042380; -.
DR   MIM; 608370; gene.
DR   neXtProt; NX_Q86SK9; -.
DR   OpenTargets; ENSG00000145284; -.
DR   PharmGKB; PA134934692; -.
DR   eggNOG; KOG1600; Eukaryota.
DR   eggNOG; COG1398; LUCA.
DR   GeneTree; ENSGT00530000063158; -.
DR   HOGENOM; HOG000270352; -.
DR   HOVERGEN; HBG003367; -.
DR   InParanoid; Q86SK9; -.
DR   KO; K00507; -.
DR   OMA; GLWWAHI; -.
DR   OrthoDB; EOG091G0B5S; -.
DR   PhylomeDB; Q86SK9; -.
DR   TreeFam; TF313251; -.
DR   BRENDA; 1.14.19.1; 2681.
DR   Reactome; R-HSA-75105; Fatty Acyl-CoA Biosynthesis.
DR   GenomeRNAi; 79966; -.
DR   PRO; PR:Q86SK9; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000145284; -.
DR   CleanEx; HS_SCD5; -.
DR   Genevisible; Q86SK9; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0004768; F:stearoyl-CoA 9-desaturase activity; IDA:UniProtKB.
DR   GO; GO:0035338; P:long-chain fatty-acyl-CoA biosynthetic process; TAS:Reactome.
DR   GO; GO:0006636; P:unsaturated fatty acid biosynthetic process; IDA:UniProtKB.
DR   CDD; cd03505; Delta9-FADS-like; 1.
DR   InterPro; IPR015876; Acyl-CoA_DS.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR001522; FADS-1_CS.
DR   PANTHER; PTHR11351; PTHR11351; 1.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   PRINTS; PR00075; FACDDSATRASE.
DR   PROSITE; PS00476; FATTY_ACID_DESATUR_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Iron;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Metal-binding;
KW   Oxidoreductase; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    330       Stearoyl-CoA desaturase 5.
FT                                /FTId=PRO_0000312653.
FT   TOPO_DOM      1     49       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     50     70       Helical. {ECO:0000255}.
FT   TOPO_DOM     71     72       Lumenal. {ECO:0000305}.
FT   TRANSMEM     73     93       Helical. {ECO:0000255}.
FT   TOPO_DOM     94    193       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM    194    214       Helical. {ECO:0000255}.
FT   TOPO_DOM    215    215       Lumenal. {ECO:0000305}.
FT   TRANSMEM    216    238       Helical. {ECO:0000255}.
FT   TOPO_DOM    239    330       Cytoplasmic. {ECO:0000305}.
FT   MOTIF        94     99       Histidine box-1. {ECO:0000305}.
FT   MOTIF       131    135       Histidine box-2. {ECO:0000305}.
FT   MOTIF       272    276       Histidine box-3. {ECO:0000305}.
FT   METAL        94     94       Iron 1. {ECO:0000250|UniProtKB:P13516}.
FT   METAL        99     99       Iron 1. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       131    131       Iron 1. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       134    134       Iron 2. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       135    135       Iron 1. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       243    243       Iron 2. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       272    272       Iron 2. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       275    275       Iron 1. {ECO:0000250|UniProtKB:P13516}.
FT   METAL       276    276       Iron 2. {ECO:0000250|UniProtKB:P13516}.
FT   BINDING      49     49       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     122    122       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     129    129       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     130    130       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     162    162       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     163    163       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   BINDING     236    236       Substrate.
FT                                {ECO:0000250|UniProtKB:O00767}.
FT   VAR_SEQ     190    330       KYYKISVVLMCFVVPTLVPWYIWGESLWNSYFLASILRYTI
FT                                SLNISWLVNSAAHMYGNRPYDKHISPRQNPLVALGAIGEGF
FT                                HNYHHTFPFDYSASEFGLNFNPTTWFIDFMCWLGLATDRKR
FT                                ATKPMIEARKARTGDSSA -> NTQHIQKEGRALNQEAACE
FT                                MLREWHQGHILKVTLPGLHILALLHTHCNHSEKCCLMLRAL
FT                                SVSLEVF (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_029883.
FT   CONFLICT     82     82       F -> L (in Ref. 2; BAB14961).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       W -> R (in Ref. 1; AAP31443 and 2;
FT                                BAB14961). {ECO:0000305}.
SQ   SEQUENCE   330 AA;  37610 MW;  50652E942C19DB82 CRC64;
     MPGPATDAGK IPFCDAKEEI RAGLESSEGG GGPERPGARG QRQNIVWRNV VLMSLLHLGA
     VYSLVLIPKA KPLTLLWAYF CFLLAALGVT AGAHRLWSHR SYRAKLPLRI FLAVANSMAF
     QNDIFEWSRD HRAHHKYSET DADPHNARRG FFFSHIGWLF VRKHRDVIEK GRKLDVTDLL
     ADPVVRIQRK YYKISVVLMC FVVPTLVPWY IWGESLWNSY FLASILRYTI SLNISWLVNS
     AAHMYGNRPY DKHISPRQNP LVALGAIGEG FHNYHHTFPF DYSASEFGLN FNPTTWFIDF
     MCWLGLATDR KRATKPMIEA RKARTGDSSA
//
